Christina Larkin
2016
In 2016, Christina Larkin earned a total compensation of $409.4K as Chief Operating Officer at Spero Therapeutics.
Compensation breakdown
| Bonus | $69,240 |
|---|---|
| Option Awards | $105,146 |
| Salary | $234,448 |
| Other | $526 |
| Total | $409,360 |
Larkin received $234.4K in salary, accounting for 57% of the total pay in 2016.
Larkin also received $69.2K in bonus, $105.1K in option awards and $526 in other compensation.
Rankings
In 2016, Christina Larkin's compensation ranked 11,851st out of 14,075 executives tracked by ExecPay. In other words, Larkin earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,851 out of 14,075 | 16th |
Division Manufacturing | 4,636 out of 5,486 | 16th |
Major group Chemicals And Allied Products | 1,662 out of 1,900 | 13th |
Industry group Drugs | 1,348 out of 1,543 | 13th |
Industry Pharmaceutical Preparations | 1,039 out of 1,173 | 11th |
Source: SEC filing on April 27, 2018.
Larkin's colleagues
We found one more compensation record of an executive who worked with Christina Larkin at Spero Therapeutics in 2016.
2016
Ankit Mahadevia
Spero Therapeutics